Carisoprodol intoxications and serotonergic features

Clinical Toxicology

Volumn 43, Issue 1, 2005, Pages 39-45

  Bramness, Jørgen G ^a   Mørland, Jørg ^a   Sørlid, Hanne Kristin ^b   Rudberg, Nina ^c   Jacobsen, Dag ^c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Direct for Hlth and Social Affairs ^*  (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Carisoprodol; Intoxications; Meprobamate; Serotonin syndrome

Indexed keywords

CARISOPRODOL; MEPROBAMATE; SEROTONIN; ACETYLCYSTEINE; DIAZEPAM; SOMADRIL COMP;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMA; DEPRESSION; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG MONITORING; FEMALE; HUMAN; HYPERTENSION; HYPOCALCEMIA; LACTIC ACIDOSIS; MYOCLONUS; SEROTONIN SYNDROME; SUICIDE ATTEMPT; TACHYCARDIA; TENDON REFLEX; CENTRAL NERVOUS SYSTEM; CONCENTRATION (PARAMETERS); LABORATORY TEST; LIVER INJURY; SEROTONINERGIC SYSTEM; SYMPTOMATOLOGY;

ADULT; CARISOPRODOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MUSCLE RELAXANTS, CENTRAL; OVERDOSE; SEROTONIN SYNDROME;

EID: 13144288985     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-45020     Document Type: Article

References (42)

1. Berger F, Kletzkin M, Ludwig B, Margolin S. The history, chemistry, and pharmacology of carisoprodol. Ann N Y Acad Sci 1959; 86:90-107.
2. Brandslund I. A case of acute carisoprodol poisoning. Symptoms and metabolism. Ugeskr Laeger 1976; 138(5):281-283.
3. Olsen H, Koppang E, Alvan G, Mørdand J. Carisoprodol elimination in humans. Ther Drug Monit 1995; 16:337-340.
4. Dalen P, Alvan G, Wakelkamp M, Olsen H. Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 1996; 6(5):387-394.
5. del Castillo J, Nelson T. The mode of action of carisoprodol. Ann N Y Acad Sci 1960; 86:108-142.
6. Goth A, Shore P. Medical Pharmacology. Mosby: St. Louis, 1978.
7. Elenbaas JK. Centrally acting oral skeletal muscle relaxants. Am J Hosp Pharm 1980; 37(10):1313-1323.
8. Littrell RA, Hayes LR, Stillner V. Carisoprodol (Soma): a new and cautious perspective on an old agent. South Med J 1993; 86(7):753-756.
9. Hobbs W, Rall T, Verdoorn T. Hypnotics and sedatives: ethanol. In: Hardman J, Limbird L, eds. Goodman & Gilman's Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1995:361-396.
10. Ashford J, Cobby J. The effects of alcohol and meprobamate applied singly and jointly in human subjects. III. The concentrations of alcohol and meprobamate in blood and their effects on performance; application of mathematical models. J Stud Alcohol, Suppl 1975; 7:140-161.
11. Rho JM, Donevan SD, Rogawski MA. Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther 1997; 280(3):1383-1391.
12. Roache JD, Griffiths RR. Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther 1987; 243(3):978-988.
13. Bailey DN, Briggs JR. Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 2002; 117(3):396-400.
14. Elder NC. Abuse of skeletal muscle relaxants. Am Fam Phys 1991; 44(4):1223-1226.
15. Lebby TI, Dugger K, Lipscomb JW, Leikin JB. Skeletal muscle relaxant ingestion. Vet Hum Toxicol 1990; 32(2):133-135.
16. Littrell RA, Sage T, Miller W. Meprobamate dependence secondary to carisoprodol (Soma) use. Am J Drug Alcohol Abuse 1993; 19(1):133-134.
17. Morse RM, Chua L. Carisoprodol dependence: a case report. Am J Drug Alcohol Abuse 1978: 5(4):527-530.
18. Rust GS, Hatch R, Gums JG. Carisoprodol as a drug of abuse. Arch Fam Med 1993; 2(4):429-432.
19. Wyller T, Korsmo G, Gadeholt G. Carisoprodol-dependence. A prospective withdrawal study among prisoners. Tidsskr Nor Laegeforen 1991; 111(2):193-195.
20. Hollister LE. The pre-benzodiazepine era. J Psychoact Drugs 1983; 15(1-2):9-13.
21. Goldberg D. Carisoprodol toxicity. Mil Med 1969; 134:597-601.
22. Roth BA, Vinson DR, Kim S. Carisoprodol-induced myoclonic encephalopathy. J Toxicol, Clin Toxicol 1998; 36(6):609-612.
23. Bramness J, Skurtveit S, Mørland J. Impairment due to intake of carisoprodol. Drug Alcohol Depend 2004; 74(3):311-318.
24. Roberge RJ, Lin E, Krenzelok EP. Flumazenil reversal of carisoprodol (Soma) intoxication. J Emerg Med 2000; 18(1):61-64.
25. Shane A, Hirsch S. Three cases of meprobamate poisoning. Canad MAJ 1956; 74:908-909.
26. Bedson H. Coma due to meprobamate intoxication. Report of a case confirmed by chemical analysis. Lancet 1959; 273(1):288-290.
27. Allen MD, Greenblatt DJ, Noel BJ. Meprobamate overdosage: a continuing problem. Clin Toxicol 1977; 11(5):501-515.
28. Blumberg A, Rosett H, Dobrow A. Severe hypotension reactions following meprobamate overdosage. Ann Intern Med 1959; 51:607-612.
29. Jacobsen D, Wiik-Larsen E, Saltvedt E, Bredesen JE. Meprobamate kinetics during and after terminated hemoperfusion in acute intoxications. J Toxicol, Clin Toxicol 1987; 25(4):317-331.
30. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148(6):705-713.
31. Hegerl U, Bottlender R, Gallinat J, Kurs HJ, Ackenheil M, Moller HJ. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998; 248(2):96-103.
32. Kaneda Y, Ohmori T, Fujii A. The serotonin syndrome: investigation using the Japanese version of the Serotonin Syndrome Scale. Psychiatry Res 2001; 105(1-2):135-142.
33. Radomski JW, Dursan SM, Reveley MA, Kutcher SP. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 2000; 55(3):218-224.
34. Kucharczyk N, Segelman FH, Kelton E, Summers J, Sofia RD, Mahrous H, Heath R. Gas chromatographic determination of carisoprodol in human plasma. J Chromatogr 1986; 377:384-390.
35. Gaillard Y, Billault F, Pepin G. Meprobamate overdosage: a continuing problem. Sensitive GC-MS quantitation after solid phase extraction in 19 fatal cases. Forensic Sci Int 1997; 86(3):173-180.
36. Lhoste F, Lemaire F, Rapin M. Treatment of hypotension in meprobamate poisoning. N Engl J Med 1977; 296(17):1004.
37. Li P, Zhuo M. Cholinergic, noradrenergic, and serotonergic inhibition of fast synaptic transmission in spinal lumbar dorsal horn of rat. Brain Res Bull 2001; 54(6):639-647.
38. Sandyk R. L-Dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine. J Clin Psychopharmacol 1986; 6:194-195.
39. Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998; 16(4):615-619.
40. Lappin R, Auchinloss E. Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 1994; 331:1021-1022.
41. Guze B, Baxter LJ. The serotonin syndrome: case responsive to propanolol. J Clin Psychopharmacol 1986; 6:119-120.
42. Logan BK, Case GA, Gordon AM. Carisoprodol, meprobamate, and driving impairment. J Forensic Sci 2000; 45(3):619-623.